alexa Plasma Rich In Growth Factors In Drops For Treatment Of Dry Eye In Patients With Graft Versus Host Disease | 61198
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

10th International Conference on Clinical & Experimental Ophthalmology

Ronald Mauricio Sanchez-Avila
University of Oviedo, Spain
Posters & Accepted Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.C1.049
Abstract
Purpose: Evaluate the therapeutic effect of plasma rich in growth factors (PRGF) in the form of eye drops, for the treatment of dry eye in patients with graft-versus-host disease (GVHD) in chronic phase, developed post-transplant bone marrow. Methods: Four patients with GVHD in chronic phase after transplantation of Allogeneic Hematopoietic Stem Cell (Allo-HSC) have been diagnosed with dry eye syndrome refractory to conventional treatment (including autologous serum). They were evaluated in this description of clinical cases. The PRGF was extracted from the serum of each patient studied, and also quantitative records symptoms (Visual Analogue Scale: frequency and severity of symptoms) were obtained. Psychometric Survey of Dry Eye (OSDI), visual acuity test, tear breakup time (tBUT) and Schirmer’s test without anesthesia; these measures were taken before initiation of treatment with PRGF. In the next week, month, and then in successive visits, even some patients have been followed for more than a year. Results: Four patients were selected, three of whom were men and one woman. The age was understood between 47 and 61 years (mean age, 54.5±5.73). After four weeks of treatment the OSDI test (Ocular Surface Disease Index) decreased significantly: 59% (initial OSDI: 45.5±6.24; final OSDI: 19±2.45); the decrease in Visual Analog Scale (VAS) was not significant in frequency, however for VAS-Severity tends to a significant statistical difference. For visual acuity of the most affected eye, a mean improvement of 33.3% was found, results also found improvement in tBUT and Schirmer’s test. No significant adverse effects as a result of PRGF treatment were found during the monitoring period. Conclusions: In patients with graft-versus-host disease chronic phase, who have developed severe dry eye syndrome, and have had previous conventional treatments without improvement, including the use of autologous serum; now have the option of treatment with eye drops PRGF. This therapy shows improvement of symptoms, findings on physical examination as tBUT and very importantly achieves improvement in visual acuity test.
Biography

Ronald Avila Sanchez completed his training as a physician at the age of 26 years (National University of Colombia). He has completed postgraduate studies in: R & D of drugs, Health Management, have an MBA. Currently he is completing his training as an ophthalmologist at the Hospital Universitario Central de Asturias, and is a doctoral candidate to the research of Ophthalmology and Vision Sciences (Univesidad of Oviedo, Eye Research Foundation, ophthalmological Institute Fernandez-Vega). Results of his research have been presented at national and international congresses ophthalmology. The research results are pending publication (5 articles of international journals).

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7